Skip to main content Back to Top
Advertisement

7/13/2022

Tropicamide 1% Ophthalmic Solution

Products Affected - Description

    • Tropicamide ophthalmic solution, Akorn, 1%, 15 mL bottle, 1 count, NDC 17478-0102-12
    • Tropicamide ophthalmic solution, Bausch Health, 1%, 2 mL bottle, 1 count, NDC 24208-0585-59

Reason for the Shortage

    • Akorn has tropicamide 1% ophthalmic drops available.
    • Alcon has Mydriacyl available.
    • Bausch Health did not provide a reason for the shortage.
    • Sandoz has tropicamide 1% ophthalmic drops available.
    • Somerset has tropicamide 1% ophthalmic drops available.

Available Products

    • Mydriacyl ophthalmic solution, Alcon Labs, 1%, 15 mL bottle, 1 count, NDC 00065-0355-15
    • Tropicamide ophthalmic solution, Sandoz, 1%, 15 mL bottle, 1 count, NDC 61314-0355-02
    • Tropicamide ophthalmic solution, Sandoz, 1%, 3 mL bottle, 1 count, NDC 61314-0355-01
    • Tropicamide ophthalmic solution, Somerset Therapeutics LLC, 1%, 15 mL bottle, 1 count, NDC 70069-0121-01

Estimated Resupply Dates

    • Akorn has tropicamide 1% in 15 mL bottles on back order and the company estimates a release date of mid-August 2022.
    • Bausch Health has tropicamide 1% in 2 mL bottles on long-term back order and the company cannot estimate a release date.

Updated

Updated July 13, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 20, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.